IFP Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

IFP Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-295	Closed	-$6K	–	4900
2022 Q3	$6K	Buy	+295	New	+$290	﹤0.01%	3978

Other funds holding SPPI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

IFP Advisors's SPPI Position: Q4 2022 in Review

IFP Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2022, closing a stake of 295 shares — an estimated $6K sold.

IFP Advisors first reported a position in SPPI in Q3 2022 and held it in 1 quarter. The position peaked at $6K in Q3 2022. 70 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.

IFP Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2022 after selling out during the quarter.
IFP Advisors sold 295 Spectrum Pharmaceuticals Inc shares in Q4 2022, an estimated $6K.
IFP Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q3 2022 and held it in 1 quarter.
IFP Advisors's Spectrum Pharmaceuticals Inc position peaked at $6K in Q3 2022.
70 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2022.

Based on IFP Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.